Send your comments and tips to whitecoat@globe.com
  Awards Beth Israel Deaconess Medical Ctr. Boston Medical Center Boston University Brigham and Women's Hospital Broad Institute Cambridge Health Alliance Caritas St. Elizabeth's Medical Ctr. Children's Hospital Boston Dana-Farber Cancer Institute Grants Harvard University Joslin Diabetes Center Lahey Clinic Mass. General Hospital Mass. Health Law McLean Hospital MIT New England Baptist Hospital Personnel Moves Public Health Research Short White Coat Tufts-New England Medical Center Tufts University UMass Memorial Medical Center University of Massachusetts VA Medical Centers    A Healthy Blog Running A Hospital Nature Network Boston SciBos - Corie Lok's blog Kevin, M.D. Blog, MD Nurse at small Dr. Gwenn Is In Healthy Children blog WBUR's CommonHealth Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram &
Gazette.
Boston Globe Health and Science staff:
Scott Allen Alice Dembner Carey Goldberg Liz Kowalczyk Stephen Smith Colin Nickerson Beth Daley Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor. Short White Coat blogger Ishani Ganguli Short White Coat blogger Jennifer Srygley  Week of:
November 11
Week of:
November 4
Week of:
October 28
Week of:
October 21
Week of:
October 14
Week of:
October 7
|
« Lahey analysis: Diabetes drugs increase risk of heart failure but not death | Main | Emotional response: Journal readers write about dealing with a patient's death » Friday, September 28, 2007Today's Globe: Novartis-MIT plan, smoky building ban, FDA clinical trials oversight, Rx drug safety, Roger Jeanloz, Edmund SonnenblickDrug giant Novartis AG says it will give its Cambridge neighbor, MIT, $65 million over 10 years to create a research program, likely to be the biggest in the world aimed at revolutionizing the way drugs are made. There are smoke-free offices, smoke-free bars, smoke-free malls. Could smoke-free apartment houses and condo towers be next? The Food and Drug Administration does very little to ensure the safety of the millions of people who participate in clinical trials, a federal investigator has found. The Food and Drug Administration yesterday gained broad new powers to ensure the safety of prescription drugs used by millions of Americans under a bill signed by President Bush.
Dr. Edmund H. Sonnenblick, a cardiologist whose research formed a basis for the modern treatment of heart failure, which has extended the lives of millions of people, died Saturday at his home in Darien, Conn. He was 74. Posted by Elizabeth Cooney at 06:55 AM
|
After a lengthy career at Harvard Medical School as a researcher and professor of biological chemistry and molecular pharmacology, 
